https://www.indianpharmapost.com/zydus-cadilas-covid-vaccine-in-advance-stage-of-trial-q4-fy21-income-up-3-88712021-05-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/tlc-partners-strides-to-launch-mucormycosis-drug-in-india-88722021-05-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-receives-us-50-mn-on-achieving-cancer-milestone-88732021-05-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/remdesivir-demand-was-exaggerated-dr-sharvil-patel-88762021-05-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/bharat-biotech-signs-mou-with-gcvc-for-covid-vaccine-88802021-05-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/sun-pharma-acquires-rights-for-oxra-oxramet-and-oxraduo-from-astrazeneca-88882021-05-28T00:00:00+05:30always0.9